---
id: 085
title: Infective Endocarditis Duke Criteria and Empiric Therapy
category: clinical_syndromes
subcategory: endocarditis
tags: [endocarditis, Duke-criteria, MRSA, viridans-strep, empiric-therapy]
difficulty: medium
---

## Question

What are the Modified Duke Criteria and empiric therapy for IE? Use the **"2 Major or 1 Major + 3 Minor or 5 Minor = Definite IE"** mnemonic.

## Answer

### **Modified Duke Criteria:**

**Major Criteria:**
1. **Positive blood cultures** (typical IE organisms):
   - **2 separate blood cultures** positive for typical organisms (*S. aureus*, viridans strep, *S. bovis*, HACEK, enterococci, community-acquired *S. aureus* without primary focus) OR
   - Persistently positive blood cultures (drawn >12 hours apart or 3/3 or majority positive)

2. **Evidence of endocardial involvement:**
   - **Positive echocardiogram** (vegetation, abscess, new valve regurgitation, dehiscence of prosthetic valve)
   - **TEE recommended** (more sensitive than TTE)

**Minor Criteria:**
1. **Predisposing condition** (prosthetic valve, IVDU, structural heart disease)
2. **Fever** ≥38°C
3. **Vascular phenomena** (emboli, mycotic aneurysm, Janeway lesions)
4. **Immunologic phenomena** (Osler nodes, Roth spots, RF, glomerulonephritis)
5. **Microbiologic evidence** (positive culture not meeting major criteria)

**Diagnosis:**
- **Definite IE:** 2 major OR 1 major + 3 minor OR 5 minor
- **Possible IE:** 1 major + 1 minor OR 3 minor

### **Empiric Therapy:**

**Native Valve IE (community-acquired):**
- **Vancomycin** 15 mg/kg IV q12h + **gentamicin** 1 mg/kg IV q8h

**Native Valve IE (subacute, suspect viridans strep):**
- **Ceftriaxone** 2g IV daily ± gentamicin (first 2 weeks)

**Prosthetic Valve IE (early <1 year):**
- **Vancomycin** + **gentamicin** + **rifampin** 300mg PO q8h

**IVDU-Associated IE:**
- **Vancomycin** (covers MRSA, most common in IVDU)
- Consider adding **gentamicin** if severely ill

## Key Points

### **Common Pathogens by Scenario:**

| Scenario | Most Likely Organism | Treatment |
|----------|---------------------|-----------|
| **Native valve, subacute** | **Viridans streptococci** | PCN G or ceftriaxone × 4 weeks |
| **Native valve, acute** | ***S. aureus*** | Nafcillin/oxacillin (or vanc if MRSA) × 6 weeks |
| **IVDU** | ***S. aureus*** (often MRSA) | Vancomycin × 6 weeks |
| **Prosthetic valve (early)** | **CoNS** (coag-neg staph), *S. aureus* | Vanc + rifampin + gent × 6 weeks |
| **Prosthetic valve (late)** | Viridans strep, enterococci | Similar to native valve |

### **Key Management Points:**

**Blood Cultures:**
- **3 sets from different sites** before antibiotics
- Ideally 1 hour apart (can be faster if unstable)
- Most will be positive in first 2 sets

**Echocardiography:**
- **TEE preferred** (sensitivity 90-100% vs TTE 40-60%)
- Repeat TEE if initial negative but high suspicion
- **Always** get echo in suspected IE

**Duration:**
- **Native valve:** 4-6 weeks (depends on organism)
- **Prosthetic valve:** 6 weeks minimum
- **Complicated (abscess, MRSA):** Often ≥6 weeks

**Surgery Indications:**
- Heart failure (most common)
- Uncontrolled infection (persistent bacteremia >5-7 days)
- Perivalvular extension (abscess, fistula)
- Large vegetations (>10mm) with embolic events
- Fungal endocarditis

### **Clinical Pearls:**
- **TEE** more sensitive than TTE (get TEE for suspected IE)
- **3 blood culture sets** before antibiotics
- **Viridans strep** = subacute, native valve
- ***S. aureus*** = acute, IVDU, aggressive
- **Surgery** for HF, uncontrolled infection, abscess
- Duration: **4-6 weeks** (native), **6 weeks** (prosthetic)

## Sources

- [AHA: Infective Endocarditis Guidelines]
- [ESC: Infective Endocarditis Guidelines]

## Media

N/A
